Physicochemical Properties
| Molecular Formula | C19H23CLN4O6 |
| Molecular Weight | 438.8621 |
| Exact Mass | 438.13 |
| CAS # | 2245697-86-1 |
| PubChem CID | 134160248 |
| Appearance | White to off-white solid powder |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Heavy Atom Count | 30 |
| Complexity | 696 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | Cl[H].O(C([H])([H])C(N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H])=O)C1=C([H])C([H])=C([H])C2=C1C(N(C2=O)C1([H])C(N([H])C(C([H])([H])C1([H])[H])=O)=O)=O |
| InChi Key | UZDTXDUTMCCMDO-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C19H22N4O6.ClH/c20-8-1-2-9-21-15(25)10-29-13-5-3-4-11-16(13)19(28)23(18(11)27)12-6-7-14(24)22-17(12)26;/h3-5,12H,1-2,6-10,20H2,(H,21,25)(H,22,24,26);1H |
| Chemical Name | N-(4-aminobutyl)-2-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]oxyacetamide;hydrochloride |
| Synonyms | ThalidomideOamidoC4NH2 HCl; Thalidomide O amido C4 NH2 HCl |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | One amine intermediate that can be employed as a heterobifunctional PROTAC BET degrader is thalidomide-O-amido-C4-NH2 (Compound 41). The proteins that make up the bromodomain and extra-terminal (BET) family, which includes testis-specific BRDT members, BRD2, BRD3, and BRD4, are known as epigenetic "readers" and are essential for controlling gene transcription. Therapeutic targets for cancer and other human disorders are thought to be appealing in the case of BET proteins. In order to cause BET protein degradation, heterobifunctional small-molecule BET degraders have recently been developed[1] using the proteolysis targeting chimera (PROTAC) idea. A degron-linker is thalidomide-O-amido-C4-NH2 (see Compound DL6-TL). Degron-linker-targeting ligand: in this system, the linker is covalently bound to a minimum of one degron and a minimum of one targeting ligand. The degron can bind to an E3 ubiquitin ligase, like cereblon, while the targeting ligand can bind to the targeted protein (s)[2]. |
| References |
[1]. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins withPicomolar Cellular Potencies and Capable of Achieving Tumor Regression.J Med Chem. 2018 Jan 25;61(2):462-481. [2]. Methods to induce targeted protein degradation through bifunctional molecules. WO 2017024317 A2. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~250 mg/mL (~569.66 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.74 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.74 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (4.74 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.2786 mL | 11.3932 mL | 22.7863 mL | |
| 5 mM | 0.4557 mL | 2.2786 mL | 4.5573 mL | |
| 10 mM | 0.2279 mL | 1.1393 mL | 2.2786 mL |